AdaptHealth Future Growth
Future criteria checks 3/6
AdaptHealth is forecast to grow earnings and revenue by 70.9% and 6.4% per annum respectively. EPS is expected to grow by 66.4% per annum. Return on equity is forecast to be 10.3% in 3 years.
Key information
70.9%
Earnings growth rate
66.44%
EPS growth rate
| Healthcare earnings growth | 19.1% |
| Revenue growth rate | 6.4% |
| Future return on equity | 10.34% |
| Analyst coverage | Good |
| Last updated | 03 Jun 2026 |
Recent future growth updates
Recent updates
Narrative Update • Jun 06
AHCO: Capitation Contract Execution Will Support Future Cash Flow Repricing
Narrative Update on AdaptHealth Analysts lifted the fair value estimate for AdaptHealth stock from $17 to $18, reflecting recent price target revisions across several firms that cite updated views on the company’s outlook and valuation assumptions. Analyst Commentary Recent Street research on AdaptHealth has centered on a series of price target resets, with several bullish analysts adjusting their models and one taking a more cautious stance.
Narrative Update • May 22
AHCO: Capitated Contract Investments And Legal Settlement Will Shape Future Earnings Profile
Analysts have nudged their average price target on AdaptHealth higher to about $11.00 from $9.50, reflecting updated views on valuation inputs such as a higher assumed future P/E multiple and recent mixed target changes across firms raising and lowering their dollar-based estimates. Analyst Commentary Recent Street research on AdaptHealth reflects a mix of optimism and caution, with some firms lifting price targets and others trimming them as they reassess assumptions around earnings quality, execution and balance sheet risk.Narrative Update • Apr 25
AHCO: Capitated Contract Ramp And Legal Settlement Will Pressure Future Earnings
Analysts have nudged their price targets for AdaptHealth higher by about $1 to $1.50, citing updated views on discount rates, revenue growth, profit margins, and future P/E assumptions reflected in the latest model tweaks. Analyst Commentary Recent research updates show a mixed but generally cautious tone around AdaptHealth, even as some targets move higher at the margin.Narrative Update • Apr 10
AHCO: Capitation Contract Execution Will Drive Future Cash Flow Upside
Narrative Update on AdaptHealth Analysts have trimmed their price targets on AdaptHealth, with recent moves including cuts to $9.50 and $14. This reflects mixed views as they weigh operational progress, new capitation business, and recent EBITDA shortfalls and legal costs.Narrative Update • Mar 27
AHCO: Forward Contract Ramp And Legal Settlement Will Pressure Profitability
Analysts have trimmed AdaptHealth's consensus price target by $1 to $9.50, reflecting updated views on fair value, discount rates, and profitability after recent operational and legal developments. Analyst Commentary Bearish analysts have recently reset expectations on AdaptHealth, trimming price targets and calling out execution risks tied to both operations and legal events.Narrative Update • Mar 13
AHCO: Capitation Ramp And Cash Generation Will Drive Future Upside Potential
Analysts have trimmed their price targets on AdaptHealth, with recent cuts such as $10.50 to $9.50 and $15 to $14. These changes reflect updated views on the impact of increased upfront investment in a major capitated contract and a debt collection settlement on near term earnings.Narrative Update • Feb 27
AHCO: Capitation Ramp And Aging At Home Focus Will Support Upside
Narrative Update on AdaptHealth Analysts have trimmed their price targets on AdaptHealth, with recent cuts such as $10.50 to $9.50 and $15 to $14. These changes reflect updated views on the company after operational progress in 2025 was offset by the timing of investments to ramp a large capitated contract and a debt collection legal settlement in North Carolina that affected adjusted EBITDA versus guidance and estimates.Narrative Update • Feb 13
AHCO: Connected Health Initiative Will Support Aging At Home Upside
Analysts have kept their $17.00 price target for AdaptHealth unchanged, citing slightly adjusted assumptions around the discount rate, revenue growth, profit margins, and future P/E as the main reasons for maintaining their view. What's in the News AdaptHealth is participating in a new Digital Medicine Society initiative focused on using connected health technology to support independent living for older adults at home.Narrative Update • Jan 30
AHCO: Digital Home Health Initiative Will Support Aging At Home Upside
Analysts are holding their fair value estimate for AdaptHealth at US$17.00 per share, citing only modest tweaks to assumptions around discount rate, revenue growth, profit margin and future P/E that do not materially change their overall view. What's in the News AdaptHealth is participating in a Digital Medicine Society initiative focused on technology driven support for older adults living independently, working alongside partners including Validic, Epic Systems, Verizon and Withings to expand connected care and remote monitoring capabilities (Key Developments).Narrative Update • Jan 16
AHCO: Digital Home Health Initiative Will Support Aging At Home Opportunity
Analysts have lifted their price target on AdaptHealth from US$16.00 to US$17.00 as they factor in updated assumptions around discount rates, revenue growth, profit margins, and future P/E expectations. What's in the News AdaptHealth is participating in a Digital Medicine Society initiative focused on technology driven support for independent living among older adults, working alongside partners such as Validic, Epic Systems, Verizon, and Withings within the Connected Health Collaborative.Analysis Article • Jan 03
AdaptHealth (NASDAQ:AHCO) Takes On Some Risk With Its Use Of Debt
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Analysis Article • Oct 18
Here's What's Concerning About AdaptHealth's (NASDAQ:AHCO) Returns On Capital
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'd want to...Analysis Article • Aug 08
AdaptHealth Corp. Just Missed EPS By 31%: Here's What Analysts Think Will Happen Next
NasdaqCM:AHCO 1 Year Share Price vs Fair Value Explore AdaptHealth's Fair Values from the Community and select yours...Analysis Article • Jul 23
Insufficient Growth At AdaptHealth Corp. (NASDAQ:AHCO) Hampers Share Price
AdaptHealth Corp.'s ( NASDAQ:AHCO ) price-to-sales (or "P/S") ratio of 0.4x might make it look like a buy right now...Analysis Article • Jun 26
Is It Time To Consider Buying AdaptHealth Corp. (NASDAQ:AHCO)?
AdaptHealth Corp. ( NASDAQ:AHCO ), might not be a large cap stock, but it led the NASDAQCM gainers with a relatively...Seeking Alpha • Jun 02
AdaptHealth At A Crossroads: Automation, Integration, And The Future Of Home Care
Summary AdaptHealth's national scale and AI-driven efficiencies position it well for value-based contracts, aiming to curb hospital readmissions and improve EBITDA margins. The company faces potential risks from competitive-bidding discounts, unresolved litigation, and execution challenges on the One Adapt ERP migration. Management's 2025 guidance suggests flat organic revenue and a 21% EBITDA margin, with shares appearing undervalued compared to peers. Long-term investors may find value in accumulating shares below 7× forward EBITDA, while monitoring integration milestones and CMS policy developments. Read the full article on Seeking Alpha
New Narrative • May 15
Adapt Operating System And Debt Reduction Will Transform Home Healthcare
AdaptHealth's focus on geographic expansion, managed care, and partnerships aims to boost market share and drive revenue growth in the home health industry.Analysis Article • May 14
We Think AdaptHealth's (NASDAQ:AHCO) Solid Earnings Are Understated
AdaptHealth Corp.'s ( NASDAQ:AHCO ) recent earnings report didn't offer any surprises, with the shares unchanged over...Analysis Article • May 09
AdaptHealth Corp. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
AdaptHealth Corp. ( NASDAQ:AHCO ) last week reported its latest quarterly results, which makes it a good time for...Analysis Article • Apr 07
Little Excitement Around AdaptHealth Corp.'s (NASDAQ:AHCO) Revenues
AdaptHealth Corp.'s ( NASDAQ:AHCO ) price-to-sales (or "P/S") ratio of 0.4x may look like a pretty appealing investment...Analysis Article • Mar 20
At US$10.02, Is It Time To Put AdaptHealth Corp. (NASDAQ:AHCO) On Your Watch List?
AdaptHealth Corp. ( NASDAQ:AHCO ), might not be a large cap stock, but it saw a decent share price growth of 19% on the...Analysis Article • Feb 26
These 4 Measures Indicate That AdaptHealth (NASDAQ:AHCO) Is Using Debt Extensively
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Analysis Article • Jan 30
Be Wary Of AdaptHealth (NASDAQ:AHCO) And Its Returns On Capital
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Analysis Article • Dec 10
AdaptHealth Corp.'s (NASDAQ:AHCO) Revenues Are Not Doing Enough For Some Investors
When close to half the companies operating in the Healthcare industry in the United States have price-to-sales ratios...Analysis Article • Nov 13
We Think AdaptHealth (NASDAQ:AHCO) Is Taking Some Risk With Its Debt
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Analysis Article • Oct 22
Returns On Capital Signal Tricky Times Ahead For AdaptHealth (NASDAQ:AHCO)
There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want...Analysis Article • Sep 06
AdaptHealth Corp.'s (NASDAQ:AHCO) Share Price Boosted 26% But Its Business Prospects Need A Lift Too
AdaptHealth Corp. ( NASDAQ:AHCO ) shareholders would be excited to see that the share price has had a great month...Analysis Article • Jul 14
Is There An Opportunity With AdaptHealth Corp.'s (NASDAQ:AHCO) 37% Undervaluation?
Key Insights Using the 2 Stage Free Cash Flow to Equity, AdaptHealth fair value estimate is US$16.89 Current share...Analysis Article • Jun 25
AdaptHealth Corp.'s (NASDAQ:AHCO) Low P/S No Reason For Excitement
When close to half the companies operating in the Healthcare industry in the United States have price-to-sales ratios...Analysis Article • Jun 04
AdaptHealth (NASDAQ:AHCO) Is Reinvesting At Lower Rates Of Return
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Analysis Article • Apr 03
Here's Why AdaptHealth (NASDAQ:AHCO) Has A Meaningful Debt Burden
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Analysis Article • Mar 07
Market Might Still Lack Some Conviction On AdaptHealth Corp. (NASDAQ:AHCO) Even After 50% Share Price Boost
AdaptHealth Corp. ( NASDAQ:AHCO ) shareholders would be excited to see that the share price has had a great month...Analysis Article • Feb 16
AdaptHealth's (NASDAQ:AHCO) Returns On Capital Not Reflecting Well On The Business
There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want...Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2028 | 3,917 | 155 | N/A | N/A | 4 |
| 12/31/2027 | 3,713 | 134 | 241 | 683 | 8 |
| 12/31/2026 | 3,488 | 107 | 178 | 606 | 8 |
| 3/31/2026 | 3,287 | -80 | 192 | 600 | N/A |
| 12/31/2025 | 3,245 | -71 | 219 | 602 | N/A |
| 9/30/2025 | 3,255 | 75 | 213 | 569 | N/A |
| 6/30/2025 | 3,241 | 73 | 231 | 552 | N/A |
| 3/31/2025 | 3,246 | 78 | 275 | 588 | N/A |
| 12/31/2024 | 3,261 | 83 | 236 | 542 | N/A |
| 9/30/2024 | 3,263 | -218 | 229 | 547 | N/A |
| 6/30/2024 | 3,261 | -693 | 166 | 501 | N/A |
| 3/31/2024 | 3,248 | -695 | 53 | 389 | N/A |
| 12/31/2023 | 3,200 | -679 | 143 | 481 | N/A |
| 9/30/2023 | 3,122 | -427 | 31 | 422 | N/A |
| 6/30/2023 | 3,075 | 42 | 22 | 431 | N/A |
| 3/31/2023 | 3,009 | 40 | 44 | 448 | N/A |
| 12/31/2022 | 2,971 | 63 | -18 | 374 | N/A |
| 9/30/2022 | 2,903 | 87 | 66 | 378 | N/A |
| 6/30/2022 | 2,800 | 125 | 20 | 298 | N/A |
| 3/31/2022 | 2,689 | 184 | 79 | 324 | N/A |
| 12/31/2021 | 2,465 | 142 | 72 | 276 | N/A |
| 9/30/2021 | 2,115 | 40 | 68 | 225 | N/A |
| 6/30/2021 | 1,746 | -64 | 124 | 232 | N/A |
| 3/31/2021 | 1,361 | -131 | 122 | 190 | N/A |
| 12/31/2020 | 1,071 | -162 | 156 | 196 | N/A |
| 9/30/2020 | 858 | -91 | 133 | 163 | N/A |
| 6/30/2020 | 710 | -44 | 124 | 145 | N/A |
| 3/31/2020 | 602 | -50 | 45 | 69 | N/A |
| 12/31/2019 | 530 | -21 | N/A | 60 | N/A |
| 9/30/2019 | 489 | -8 | N/A | 68 | N/A |
| 6/30/2019 | 454 | 8 | N/A | 72 | N/A |
| 3/31/2019 | 398 | 14 | N/A | 73 | N/A |
| 12/31/2018 | 345 | 23 | N/A | 68 | N/A |
| 12/31/2017 | 193 | 10 | N/A | 46 | N/A |
| 12/31/2016 | 174 | -4 | N/A | 30 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AHCO is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (3.5%).
Earnings vs Market: AHCO is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: AHCO is expected to become profitable in the next 3 years.
Revenue vs Market: AHCO's revenue (6.4% per year) is forecast to grow slower than the US market (12.5% per year).
High Growth Revenue: AHCO's revenue (6.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: AHCO's Return on Equity is forecast to be low in 3 years time (10.3%).
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/11 05:33 |
| End of Day Share Price | 2026/06/11 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
AdaptHealth Corp. is covered by 11 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Eric Coldwell | Baird |
| Kevin Fischbeck | BofA Global Research |
| Joanna Sylvia Gajuk | BofA Global Research |